Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Prostate. 2019 Aug 2;79(14):1589–1596. doi: 10.1002/pros.23882

Figure 1.

Figure 1

Box plots of the four-gene transcript (4GT) score in the MC testing dataset stratified by: A) prostate cancer outcome status (no recurrence vs. metastatic-lethal progression); and B) CAPRA-S score category (low-medium risk vs. high risk group)